Seeing Is Believing
Healthcare - Sector
FOLD is currently covered by 7 analysts with an average price target of $18.64. This is a potential upside of $4.37 (30.62%) from yesterday's end of day stock price of $14.27.
Amicus Therapeutics's activity chart (see below) currently has 159 price targets and 108 ratings on display. The stock rating distribution of FOLD is 87.5% BUY and 12.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 57.83% with an average time for these price targets to be met of 387.06 days.
Highest price target for FOLD is $16, Lowest price target is $9, average price target is $13.7.
Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 29-Dec-2025. First documented stock forecast 20-Aug-2014.
Currently out of the existing stock ratings of FOLD, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Jan-2022
$14.5
$0.23 (1.61%)
$14
1 months ago
(29-Dec-2025)
6/10 (60%)
$0.25 (1.75%)
465
Buy Since 04-Jan-2021
$14.5
$0.23 (1.61%)
$20
1 months 7 days ago
(22-Dec-2025)
4/10 (40%)
$3.61 (33.15%)
906
Buy Since 13-Apr-2021
$14.5
$0.23 (1.61%)
$21
1 months 10 days ago
(19-Dec-2025)
0/8 (0%)
$3.61 (33.15%)
Buy Since 18-Sep-2025
$14
1 months 10 days ago
(19-Dec-2025)
1/1 (100%)
$5.52 (65.09%)
96
Buy Since 19-Dec-2023
$12
6 months 12 days ago
(17-Jul-2025)
1/4 (25%)
$2.64 (28.21%)
375
What is FOLD (Amicus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?
Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?
Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?